CHEK2 GENE MUTATION
Clinical trials for CHEK2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new CHEK2 GENE MUTATION trials appear
Sign up with your email to follow new studies for CHEK2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough prostate cancer in understudied groups
Disease control TerminatedThis study tested a combination of two drugs (niraparib and abiraterone plus prednisone) for men with metastatic hormone-sensitive prostate cancer that has certain gene mutations. It focused on Hispanic/Latino and Black patients, who are often underrepresented in research. The go…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancers
Disease control OngoingThis study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific gene mutation that makes their cancer cells less able to repair DNA damage. The goal is to see if olaparib can shrink tumors or slo…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC